Trial Profile
Pharmacokinetic Study of Levocetirizine Oral Solution-An Open-label, Randomized, Cross-over Study to Evaluate the Pharmacokinetics, the Safety and Tolerability of Levocetirizine Oral Solution (5 mg) and Cetirizine Dry Syrup (10 mg), Following a Single Dose in Japanese Healthy Male Subjects-
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Levocetirizine (Primary) ; Cetirizine
- Indications Allergic rhinitis; Hypersensitivity; Pruritus; Urticaria
- Focus Pharmacokinetics
- Sponsors GSK
- 25 Jun 2012 New trial record